Your browser doesn't support javascript.
loading
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.
Canetti, Michal; Barda, Noam; Gilboa, Mayan; Indenbaum, Victoria; Mandelboim, Michal; Gonen, Tal; Asraf, Keren; Weiss-Ottolenghi, Yael; Amit, Sharon; Doolman, Ram; Mendelson, Ella; Harats, Dror; Freedman, Laurence S; Kreiss, Yitshak; Lustig, Yaniv; Regev-Yochay, Gili.
Afiliación
  • Canetti M; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Barda N; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Gilboa M; ARC Innovation Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Indenbaum V; Software and Information Systems Engineering, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Mandelboim M; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Gonen T; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Asraf K; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Weiss-Ottolenghi Y; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Amit S; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Doolman R; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Mendelson E; Central Virology Laboratory, Public Health Services, Ministry of Health, Tel-Hashomer, Ramat Gan, Israel.
  • Harats D; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Freedman LS; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Kreiss Y; Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Lustig Y; The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
  • Regev-Yochay G; The Infection Prevention & Control Unit, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Nat Commun ; 13(1): 7711, 2022 12 13.
Article en En | MEDLINE | ID: mdl-36513665
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article